UK-EDI: UK Early Detection Initiative for Pancreatic Cancer.

UK-EDI is a research programme funded by Cancer Research UK which will explore the link between new-onset diabetes and pancreatic cancer with the aim of finding ways to diagnose pancreatic cancer earlier.

Most cases of type 2 diabetes are due to lifestyle or genetic factors. However, in approximately 1 in 100 people, a new diagnosis of type 2 diabetes could be an early warning sign of pancreatic cancer.

Through this research we hope to develop a diagnostic test for use in individuals newly diagnosed with diabetes which will identify those most at risk of pancreatic cancer, allowing them to be screened.

The aim of UK-EDI is to detect pancreatic cancer earlier.

UK-EDI consists of seven work packages that contribute to the overall aim of the programme.

UK-EDI is hosted by the University of Liverpool in collaboration with the Liverpool Clinical Trials Centre (LCTC), Liverpool GCP labs, Liverpool ECMC and the University of Strathclyde.

Contact us
UK-EDI
Liverpool Clinical Trials Centre
University of Liverpool
1st Floor Block C Waterhouse building
Liverpool
L69 3GL
+44(0)151 794 8852
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.